CacyBP/SIP phosphatase activity in neuroblastoma NB2a and colon cancer HCT116 cells

Biochemistry and Cell Biology

Volumn 90, Issue 4, 2012, Pages 558-564

  Kilanczyk, Ewa ^a   Wasik, Urszula ^a   Filipek, Anna ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

CacyBP SIP; ERK1 2 kinase; phosphatase activity; posttranslational modification; catenin

Indexed keywords

CELL CULTURE; ELECTROPHORESIS; PHOSPHATASES; PHOSPHORYLATION;

2-D ELECTROPHORESIS; CACYBP/SIP; DIFFERENT ORIGINS; ERK1/2 KINASE; NUCLEAR FRACTIONS; OVER-EXPRESSION; PHOSPHATASE ACTIVITY; POST-TRANSLATIONAL MODIFICATIONS;

CELLS;

BETA CATENIN; CALCYCLIN BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATASE; SIAH 1 INTERACTING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HCT116; CELL STRAIN NB2A; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 84863007976     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/o2012-011     Document Type: Article

References (27)

1. Barry O.P. Multan B. Sheehan D. Kazanietz M.G. Shanahan F. Collins J.K. O’Sullivan G.C. 2001. Constitutive ERK1/2 activation in esophagogastric rib bone marrow micrometastatic cells is MEK-independent. J. Biol. Chem. 276 (18): 15537-15546. 10.1074/jbc.M010847200 11297525
2. Bhattacharya S. Lee Y.T. Michowski W. Jastrzebska B. Filipek A. Kuznicki J. Chazin W.J. 2005. The modular structure of SIP facilitates its role in stabilizing multiprotein assemblies. Biochemistry, 44 (27): 9462-9471. 10.1021/bi0502689 15996101 (Pubitemid 40962045)
3. Filipek A. KuÅ°nicki J. 1998. Molecular cloning and expression of a mouse brain cDNA encoding a novel protein target of calcyclin. J. Neurochem. 70 (5): 1793-1798. 9572262 (Pubitemid 28207800)
4. Filipek A. Wojda U. 1996. p30, a novel protein target of mouse calcyclin (S100A6). Biochem. J. 320 (2): 585-587. 8973570
5. Filipek A. Jastrzebska B. Nowotny M. Kuznicki J. 2002. CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family. J. Biol. Chem. 277 (32): 28848-28852. 10.1074/jbc.M203602200 12042313
6. Filipek A. Schneider G. Mietelska A. Figiel I. Niewiadomska G. 2008. Age-dependent changes in neuronal distribution of CacyBP/SIP: comparison to tubulin and the tau protein. J. Neural Transm. 115 (9): 1257-1264. 10.1007/s00702-008-0062-3 18506390
7. Fuchs S.Y. Ougolkov A.V. Spiegelman V.S. Minamoto T. 2005. Oncogeneic beta-catenin signaling networks in colorectal cancer. Cell Cycle, 4 (11): 1522-1539. 10.4161/cc.4.11.2129 16258275
8. Han K.K. Martinage A. 1992. Possible relationship between coding recognition amino acid sequence motif or residue(s) and post-translational chemical modification of proteins. Int. J. Biochem. 24 (9): 1349-1363. 10.1016/0020-711X(92)90060-E 1426517
9. Hoshino R. Chatani Y. Yamori T. Tsuruo T. Oka H. Yoshida O. et al. 1999. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene, 18 (3): 813-822. 10.1038/sj.onc.1202367 9989833 (Pubitemid 29080340)
10. Jastrzebska B. Filipek A. Nowicka D. Kaczmarek L. Kuznicki J. 2000. Calcyclin (S100A6) binding protein (CacyBP) is highly expressed in brain neurons. J. Histochem. Cytochem. 48 (9): 1195-1202. 10.1177/002215540004800903 10950876
11. Kilanczyk E. Filipek S. Jastrzębska B. Filipek A. 2009. CacyBP/SIP binds ERK1/2 and affects transcriptional activity of Elk-1. Biochem. Biophys. Res. Commun. 380 (1): 54-59. 10.1016/j.bbrc.2009.01.026 19166809
12. Kilanczyk E. Filipek S. Filipek A. 2011. ERK1/2 is dephosphorylated by a novel phosphatase-CacyBP/SIP. Biochem. Biophys. Res. Commun. 404 (1): 179-183. 10.1016/j.bbrc.2010.11.088 21110948
13. Laemmli U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227 (5259): 680-685. 10.1038/227680a0 5432063
14. Leszczyniecka M. Roberts T. Dent P. Grant S. Fisher P.B. 2001. Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol. Ther. 90 (2-3): 105-156. 10.1016/S0163-7258(01)00132-2 11578655 (Pubitemid 32926714)
15. Liu S. Sun J.P. Zhou B. Zhang Z.Y. 2006. Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3. Proc. Natl. Acad. Sci. U.S.A. 103 (14): 5326-5331. 10.1073/pnas.0510506103 16567630
16. Manzano R.G. Montuenga L.M. Dayton M. Dent P. Kinoshita I. Vicent S. et al. 2002. CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential. Oncogene, 21 (28): 4435-4447. 10.1038/sj.onc.1205542 12080474 (Pubitemid 34774846)
17. Matsuzawa S.I. Reed J.C. 2001. Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol. Cell, 7 (5): 915-926. 10.1016/S1097-2765(01)00242-8 11389839 (Pubitemid 32525739)
18. Morin P.J. Sparks A.B. Korinek V. Barker N. Clevers H. Vogelstein B. Kinzler K.V. 1997. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science, 275 (5307): 1787-1790. 10.1126/science.275.5307.1787 9065402 (Pubitemid 27136715)
19. Ning X. Sun S. Hong L. Liang J. Liu L. Han S. et al. 2007. Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Mol. Cancer Res. 5 (12): 1254-1262. 10.1158/1541-7786.MCR-06- 0426 18171983
20. Raff M.C. 1992. Social controls on cell survival and cell death. Nature, 356 (6368): 397-400. 10.1038/356397a0 1557121
21. Schneider G. Filipek A. 2011. S100A6 binding protein and Siah-1 interacting protein (CacyBP/SIP): spotlight on properties and cellular function. Amino Acids, 41 (4): 773-780. 10.1007/s00726-010-0498-2 20182755
22. Schneider G. Nieznanski K. Kilanczyk E. Bieganowski P. Kuznicki J. Filipek A. 2007. CacyBP/SIP interacts with tubulin in neuroblastoma NB2a cells and induces formation of globular tubulin assemblies. Biochim. Biophys. Acta, 1773 (11): 1628-1636. 10.1016/j.bbamcr.2007.07.013 17916393 (Pubitemid 350018916)
23. Schneider G. Nieznanski K. Jozwiak J. Slomnicki L.P. Redowicz M.J. Filipek A. 2010. Tubulin binding protein, CacyBP/SIP, induces actin polymerization and may link actin and tubulin cytoskeletons. Biochim. Biophys. Acta, 1803 (11): 1308-1317. 10.1016/j.bbamcr.2010.07.003 20637809
24. Sliwinska M.A. Mosieniak G. Wolanin K. Babik A. Piwocka K. Magalska A. et al. 2009. Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells. Mech. Ageing Dev. 130 (1-2): 24-32. 10.1016/j.mad.2008.04.011 18538372
25. Sun S. Ning X. Liu J. Liu L. Chen Y. Han S. et al. 2007. Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma. Biochem. Biophys. Res. Commun. 356 (4): 864-871. 10.1016/j.bbrc.2007.03.080 17400182 (Pubitemid 46529373)
26. Wang N. Ma Q. Wang Y. Ma G. Zhai H. 2010. CacyBP/SIP expression is involved in the clinical progression of breast cancer. World J. Surg. 34 (11): 2545-2552. 10.1007/s00268-010-0690-2 20585948
27. Zhai H. Shi Y. Jin H. Li Y. Lu Y. Chen X. et al. 2008. Expression of calcyclin-binding protein/Siah-1 interacting protein in normal and malignant human tissues: an immunohistochemical survey. J. Histochem. Cytochem. 56 (8): 765-772. 10.1369/jhc.2008.950519 18443365 (Pubitemid 351991089)